CR20190329A - MODULADORES DEL FACTOR DEL COMPLEMENTO B (Divisional 2016-0170) - Google Patents

MODULADORES DEL FACTOR DEL COMPLEMENTO B (Divisional 2016-0170)

Info

Publication number
CR20190329A
CR20190329A CR20190329A CR20190329A CR20190329A CR 20190329 A CR20190329 A CR 20190329A CR 20190329 A CR20190329 A CR 20190329A CR 20190329 A CR20190329 A CR 20190329A CR 20190329 A CR20190329 A CR 20190329A
Authority
CR
Costa Rica
Prior art keywords
complement factor
complement
modulators
cfb
dysregulation
Prior art date
Application number
CR20190329A
Other languages
English (en)
Inventor
Michael L Mccaleb
Tamar R Grossman
Andrew T Watt
Susan M Freier
Original Assignee
Ionis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ionis Pharmaceuticals Inc filed Critical Ionis Pharmaceuticals Inc
Priority claimed from PCT/US2014/055458 external-priority patent/WO2015038939A2/en
Publication of CR20190329A publication Critical patent/CR20190329A/es

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Las presentes modalidades proporcionan métodos, compuestos y composiciones para tratar, prevenir o mejorar una enfermedad asociada con la desregulación de la vía alternativa 5 de complemento mediante la administración de un inhibidor específico del factor del complemento B (CFB) a un sujeto.The present embodiments provide methods, compounds, and compositions for treating, preventing, or ameliorating a disease associated with dysregulation of the complement alternative pathway by administering a Complement Factor B (CFB) specific inhibitor to a subject.
CR20190329A 2014-09-12 2014-09-12 MODULADORES DEL FACTOR DEL COMPLEMENTO B (Divisional 2016-0170) CR20190329A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US2014/055458 WO2015038939A2 (en) 2013-09-13 2014-09-12 Modulators of complement factor b
US201661877624P 2016-09-13 2016-09-13

Publications (1)

Publication Number Publication Date
CR20190329A true CR20190329A (es) 2019-09-13

Family

ID=68343558

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20190329A CR20190329A (es) 2014-09-12 2014-09-12 MODULADORES DEL FACTOR DEL COMPLEMENTO B (Divisional 2016-0170)

Country Status (1)

Country Link
CR (1) CR20190329A (es)

Similar Documents

Publication Publication Date Title
CL2018001996A1 (es) Composiciones y métodos para modular la expresión del factor b del complemento (divisional de solicitud 2764-16)
CR20160170A (es) Moduladores del factor del complemento b
CL2020000215A1 (es) Compuestos y composiciones para tratar afecciones asociadas con la actividad nlrp.
BR112018004620A2 (pt) moduladores da expressão de kras
DOP2020000102A (es) Compuestos útiles para inhibir a cdk7
CO2017013065A2 (es) Moduladores de diaciglicerol aciltransferasa 2 (dgat2)
BR112017008659A2 (pt) ?métodos e compostos de agonista de gip?
NI202100018A (es) Moduladores de la expresión de pnpla3
ECSP21053104A (es) Moduladores de la expresión de hsd17b13
CR20190471A (es) Moduladores de la expresión de pcsk9
CL2020000586A1 (es) Moduladores de la expresión de enac.
BR112016015578A2 (pt) Inibidores de 17beta-hidroxiesteroide desidrogenases tipo 1 e tipo 2
CR20190329A (es) MODULADORES DEL FACTOR DEL COMPLEMENTO B (Divisional 2016-0170)
ES2721922T3 (es) Tratamiento o prevención del daño neuronal no inflamatorio por traumatismo cerebral e ictus utilizando mentol, linalool y/o icilina
AR106415A1 (es) Composición farmacéutica para el tratamiento del dolor